Medifast Outperforms American Diabetes Association Diet by Twice the Weight Loss According to Publi...( 'The Diabetes Educator' published stu...),Health

'The Diabetes Educator' published study showing Medifast's effectiveness in

patients with type 2 diabetes

OWINGS MILLS, Md., Feb. 11 /PRNewswire-FirstCall/ -- Medifast, Inc. (NYSE: MED) today announced that a study conducted by researchers at the Johns Hopkins University Bloomberg School of Public Health, showing the Medifast Program outperforms the American Diabetes Association (ADA) recommended diet for patients with type 2 diabetes, has been published in the January/February issue of 'The Diabetes Educator'. The peer-reviewed journal is the official journal of the American Association of Diabetes Educators.

The examiner of the study from Johns Hopkins University submitted the study and informed Medifast that the study has been published in the most appropriate venue to help train diabetes educators about the effectiveness of Medifast Meal Replacements in the treatment of type 2 diabetes. The study was finalized for publication within the last 12 months after being presented to physicians and scholars attending the American Diabetes Association Convention in 2005.

"This study is one of many that validate the efficacy of Medifast Meal Replacements in the clinical setting," said Brad MacDonald, Chairman of the Board, Medifast, Inc. "Medifast continues to invest in the research and development of its products and programs to ensure that our claims to consumers are the most documented and credible in the industry."

In the study, the Medifast Program outperformed the ADA recommended diet in weight loss, adherence and biochemical outcomes. These findings suggest a re-evaluation of the ADA recommendation, which currently does not promote portion-controlled meal replacement programs in weight loss
'/>"/>